Loading...
01/11 03:17
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary shows a mix of positive and negative aspects. Positive elements include partnerships with major companies and a DOE grant. However, the company faces challenges with a difficult macro environment, funding uncertainties, and competitive pressures. The Q&A reveals management's focus on core business and diversification, but vague responses on tariffs raise concerns. Despite a 16% revenue increase, significant losses and operational challenges are evident. The overall sentiment is balanced, leading to a neutral prediction for stock price movement.
Revenue $20.1 million, a $2.7 million or 16% increase compared to 2023 revenue of $17.4 million. This increase was driven primarily by the SK On agreements with strong execution on the line installation agreement and completion of key steps in the transfer of our technology accounting for $11.8 million of our 2024 revenue.
Operating Expenses $125.5 million, an increase of $17.5 million compared to 2023. This increase was driven by higher research and development costs to improve the performance of our electrolyte and cell designs, electrolyte production, equipment purchases in support of the SK On agreements and scaling of operations, including establishing Korean operations.
Operating Loss $105.3 million.
Net Loss $96.5 million or $0.54 per share.
Capital Expenditures $15.9 million, primarily investments in our electrolyte development and production capabilities, including the build out of the EIC.
Total Cash Investment $79.8 million, which was below our guidance range of $100 million to $120 million. This was due to prioritizing projects and outlays to preserve cash runway while still meeting our goals and objectives.
Total Liquidity $327.5 million.
Electrolyte Sampling Program: Increased electrolyte sampling activity, shipping to new and repeat potential customers, primarily Asian Tier 1 cell manufacturers and automotive OEMs.
Electrolyte Innovation Center (EIC): Commissioned a state-of-the-art EIC designed for flexibility to develop and test production processes at a smaller scale.
Continuous Manufacturing Process Grant: Selected by the U.S. Department of Energy for a grant of up to $50 million to install a continuous manufacturing process for sulfide-based solid electrolyte materials.
Expansion in Korea: Established a home base in Korea to drive engagement with potential customers, vendors, and research institutes.
Partnership with SK On: Deepened relationship with SK On through three agreements to support solid state cell development.
Joint Development Agreements (JDAs) with BMW and Ford: Extended JDAs to improve cell technologies and pilot scale manufacturing.
Revenue Growth: Generated revenue of $20.1 million in 2024, a 16% increase from 2023.
Operating Expenses: Operating expenses increased to $125.5 million, driven by R&D costs and scaling operations.
Capital Expenditures: Total capital expenditures of $15.9 million focused on electrolyte development and production capabilities.
Business Model Focus: Shifted focus to supplying electrolyte to cell developers rather than competing in cell manufacturing.
Operational Goals for 2025: Plans to execute on electrolyte development roadmap and maintain financial discipline while investing in technology.
Market Conditions: The company is facing a difficult macro environment with slower-than-expected EV sales and many OEMs and battery manufacturers projecting commercial adoption of solid-state batteries in the late 2020s or early 2030s.
Funding Uncertainty: There is uncertainty regarding the timing of funding under the DOE agreement due to a January 2025 executive order that paused disbursements of funds pending further review.
Operational Challenges: The company anticipates significant capital expenditures in 2025 related to facility engineering and construction of a third pilot electrolyte line, which may pose operational challenges.
Competitive Pressures: Solid Power is competing with other companies that are expanding their solid-state cell capabilities, which may impact their market position as they focus on supplying electrolyte rather than competing in cell manufacturing.
Financial Discipline: The company aims to maintain financial discipline while ensuring ongoing investments in technology development and production capabilities, which may be challenging given the projected operating loss of $105.3 million.
Electrolyte Innovation Center (EIC): Commissioned a state-of-the-art EIC to develop and test production processes for sulfide-based solid electrolyte materials.
Partnerships with SK On, BMW, and Ford: Deepened relationships with SK On through multiple agreements and extended joint development agreements with BMW and Ford.
Continuous Manufacturing Process: Selected for a $50 million DOE grant to install a continuous manufacturing process for sulfide-based solid electrolyte materials.
Korean Operations Expansion: Established a home base in Korea to enhance engagement with potential customers and partners.
2025 Revenue Expectations: Expect revenue to be consistent with or higher than 2024's $20.1 million.
2025 Cash Investment Guidance: Anticipate cash investment in the range of $100 million to $120 million, excluding DOE grant benefits.
Capital Expenditures Focus: Significant capital expenditures in 2025 will relate to facility engineering and construction of a third pilot electrolyte line.
2024 Revenue: $20.1 million, a $2.7 million or 16% increase compared to 2023.
Operating Loss: $105.3 million for the year.
Net Loss: $96.5 million or $0.54 per share.
Capital Expenditures: $15.9 million, primarily investments in electrolyte development and production capabilities.
Total Liquidity: $327.5 million at the end of 2024.
2025 Cash Investment Guidance: Expected to be in the range of $100 million to $120 million.
DOE Grant: Up to $50 million to install a continuous manufacturing process for sulfide-based solid electrolyte materials.
Despite a new partnership with Samsung SDI and BMW, the company faces significant financial challenges, including a revenue decline and high operating losses. The reduced cash investment guidance reflects fiscal discipline, but ongoing reliance on partnerships and manufacturing risks present uncertainties. With no guidance provided, the market may react negatively.
The earnings call summary shows mixed indicators: a slight revenue increase and reduced operating expenses, but ongoing net losses and uncertainties in revenue trajectory beyond 2025. Partnerships with major companies and a DOE grant are positives, but supply chain and competitive pressures pose risks. The Q&A reveals unclear guidance on future revenue, which adds to uncertainty. Given these mixed signals and the absence of clear catalysts for strong movement, the stock price is likely to remain stable in the short term, resulting in a neutral sentiment.
The earnings call reveals several concerns: an EPS miss, significant operating and net losses, and uncertainty over DOE funding. Despite revenue growth and strong liquidity, the company faces macro challenges and a competitive landscape shift. The Q&A session highlighted unclear management responses on tariffs and strategic focus. Although there are positive elements like partnerships and revenue growth, the overall sentiment is negative due to financial underperformance and strategic uncertainties.
The earnings call summary shows a mix of positive and negative aspects. Positive elements include partnerships with major companies and a DOE grant. However, the company faces challenges with a difficult macro environment, funding uncertainties, and competitive pressures. The Q&A reveals management's focus on core business and diversification, but vague responses on tariffs raise concerns. Despite a 16% revenue increase, significant losses and operational challenges are evident. The overall sentiment is balanced, leading to a neutral prediction for stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
